A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

Charité - Universitätsmedizin Berlin, Berlin

Virginia Cancer Specialists, Fairfax

Centro Oncológico MD Anderson International España, Madrid

University of Alabama at Birmingham, Birmingham

Azienda Ospedaliero Universitaria Senese, Siena

Universitätsmedizin der Johannes Gutenberg, Universität Mainz, Mainz

Mayo Clinic, Rochester

Centre Hospitalier Universitaire de Lille, Lille

Northwestern University, Chicago

University of Colorado Denver, Denver

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli

University of California San Diego, La Jolla

University of California San Francisco, San Francisco

HealthPartners Institute, Bloomington

Atlantic Health System, Morristown

Centre Georges François Leclerc, Dijon

CHU de Nantes, Nantes

AP-HP Hopital Saint-Louis, Paris

Gustave Roussy, Paris

CHU de Poitiers, Poitiers

"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori", Meldola

Hospital Clinic de Barcelona, Barcelona

Hospital Universitario 12 de Octubre, Madrid

Clínica Universidad de Navarra, Pamplona

Universitary Hospital Virgen Macarena, Seville